Write Your Own Review
You're reviewing:NS 1619
Rate this item:

Images

Biological Data

Biological description Potent and selective KCa1.1 channel activator (EC50 = 3.6 µM). Selectively increases the blood brain barrier permeability. Displays vasorelaxant properties

Solubility & Handling

Storage instructions +4°C
Solubility overview Soluble in DMSO (100mM) or ethanol (100mM)
Important This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use.

Calculators

Molarity

=
x
x
More Info

Dilution

x
=
x
More Info

Chemical Data

Purity >98%
Chemical name 1,3-Dihydro-1-[2-hydroxy-5-(trifluo romethyl)phenyl]-5-(trifluoromethyl)-2H-benzimidazol-2-one
Molecular Weight 362.23
Chemical structure NS 1619  [153587-01-0] Chemical Structure
Molecular Formula C15H8F6N2O2
CAS Number 153587-01-0
PubChem identifier 4552
SMILES O=C2NC1=CC(C(F)(F)F)=CC=C1N2C3=CC(C(F)(F)F)=CC=C3O
InChiKey YLFMCMWKHSDUCT-UHFFFAOYSA-N

References for NS 1619

References are publications that support the biological activity of the product
  • Role of ROS/RhoA/PI3K/PKB signaling in NS1619-mediated blood-tumor barrier permeability increase.

    Gu YT et al (2012) J Mol Neurosci 48(1) : 302-12.
  • Large conductance Ca2+ -activated K+ channel activation with NS1619 decreases myogenic and neurogenic contractions of rat detrusor smooth muscle.

    Soder RP et al (2011) Eur J Pharmacol 670(1) : 252-9.
  • Large-conductance K+ channel openers NS1619 and NS004 as inhibitors of mitochondrial function in glioma cells.

    Debska G et al (2003) Biochem Pharmacol 65(11) : 1827-34.
  • 5-(4'-Substituted-2'-nitroanilino)-1,2,3-triazoles as new potential potassium channel activators. I.

    Biagi G et al (2000) Eur J Med Chem 35(7-8) : 715-20.

4 Item(s)